Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci174015 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Yelena Drexler und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Drexler, Y., & Fornoni, A. (2023). Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci174015
Vancouver
Drexler Y, Fornoni A. Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease. Journal of Clinical Investigation. 2023. doi:10.1172/jci174015
BibTeX
@article{Drexler2023,
author = {Drexler, Yelena and Fornoni, Alessia},
title = {Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci174015}
}
EUVIMED